$ABBV Headlines Paulson takes stake in Abbvie, adds to

New Post Public Reply Private Reply Replies (0) Message Board

Nov 24, 2014 at 10:37 AM

$ABBV Headlines

Paulson takes stake in Abbvie, adds to Shire holdings 6:46 p.m. Nov. 14, 2014 - MarketWatch
Obama considering Lazard banker for Treasury post 4:20 p.m. Nov. 12, 2014 - Victoria McGrane
77 stocks in the S&P 500 Index rise to new highs 10:50 a.m. Nov. 12, 2014 - Philip van Doorn
Merck, Dendreon miss out on health-care rally 12:39 p.m. Nov. 10, 2014 - Russ Britt
S&P 500, Dow close at record levels 4:16 p.m. Oct. 31, 2014 - Barbara Kollmeyer
Apple rallies to record high; LinkedIn jumps 11:05 a.m. Oct. 31, 2014 - Sue Chang
AbbVie stock up 3.6% at $63.38 9:32 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie shares up 4% in premarket trade 8:52 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie raises outlook as profit, sales beat 8:26 a.m. Oct. 31, 2014 - MarketWatch.com
AbbVie shares up 2% as profit, sales beat estimates 8:00 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie prior FY EPS outlook was $3.06 to $3.16 7:54 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie's stock gains 2.2% premarket after Q3 results beat expectations 7:53 a.m. Oct. 31, 2014 - Tomi Kilgore
AbbVie raises FY EPS outlook to $3.25 to $3.27 7:53 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie Q3 FactSet revenue consensus $4.831 bln 7:53 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie Q3 FactSet EPS consensus 77 cents 7:52 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie Q3 revenue $5.019 bln, up 7.85 7:52 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie Q3 adj. EPS 89 cents 7:52 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie Q3 EPS 31 cents vs 60 cents 7:51 a.m. Oct. 31, 2014 - Ciara Linnane
Mylan 3Q profit soars as revenue tops estimates 5:19 p.m. Oct. 30, 2014 - MarketWatch.com
12 highest-yielding ‘dividend aristocrat’ stocks 10:38 a.m. Oct. 30, 2014 - Philip van Doorn

Today AbbVie (ABBV) Hits New Lifetime High 52 min ago - TheStreet.com
Tracking Dan Loeb's Third Point Portfolio - Q3 2014 Update 2:26 a.m. Today - Seeking Alpha
John Paulson's Top 5 New Holdings For Q3 9:08 p.m. Nov. 21, 2014 - GuruFocus.com
Dividend Aristocrats In Focus Part 41: Abbott Laboratories 9:01 p.m. Nov. 21, 2014 - Seeking Alpha
John Paulson's Top 5 New Holdings for Q3 8:53 p.m. Nov. 21, 2014 - GuruFocus.com
Can New Launches Offset Sanofi's Soft Diabetes Business? - Analyst Blog 5:10 p.m. Nov. 21, 2014 - Zacks.com
Amgen and AbbVie Strengthen Manufacturing Facilities in Asia - Analyst Blog 5:00 p.m. Nov. 21, 2014 - Zacks.com
Alibaba: The Top New Position For Hedge Funds 3:21 p.m. Nov. 21, 2014 - Seeking Alpha
AbbVie, Celgene, Sanofi Drugs Get EU Endorsements 11:28 a.m. Nov. 21, 2014 - Investors Business Daily
European Ad Comm gives thumbs up to AbbVie's HCV combo 8:48 a.m. Nov. 21, 2014 - Seeking Alpha
Tracking David Tepper's Appaloosa Management Portfolio - Q3 2014 Update 8:44 a.m. Nov. 21, 2014 - Seeking Alpha
J&J Seeks FDA Approval for Schizophrenia Treatment - Analyst Blog 4:45 p.m. Nov. 20, 2014 - Zacks.com
Shire to Relocate Employees Under One Shire Program - Analyst Blog 4:35 p.m. Nov. 20, 2014 - Zacks.com
Facebook Among New Holdings in Steve Mandel's Portfolio 4:31 p.m. Nov. 20, 2014 - GuruFocus.com
FDA clears Purdue's abuse-deterrent opioid 1:36 p.m. Nov. 20, 2014 - Seeking Alpha
Independent Thinking For Successful Dividend Investing 9:52 p.m. Nov. 19, 2014 - Seeking Alpha
Gilead Gains on Harvoni's EU Approval for HCV Treatment - Analyst Blog 5:57 p.m. Nov. 19, 2014 - Zacks.com
Why We're Huge Fans Of Gilead 4:33 p.m. Nov. 19, 2014 - Seeking Alpha
AstraZeneca Targets More than $45B in Revenues in 2023 - Analyst Blog 4:20 p.m. Nov. 19, 2014 - Zacks.com
Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook 1:00 a.m. Nov. 19, 2014 - Zacks.com

CHMP Grants Positive Opinions of AbbVie's VIEKIRAX™ (ombitasvir/paritaprevir/ritonavir) + EXVIERA™ (dasabuvir) for the Treatment of Chronic Hepatitis C in Europe 8:00 a.m. Nov. 21, 2014 - PR Newswire - PRF
AbbVie to Present at Jefferies 2014 Global Healthcare Conference 7:00 a.m. Nov. 17, 2014 - PR Newswire - PRF
AbbVie Presents Results from Study of ABT-414 in Patients with Glioblastoma Multiforme at the 19th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology 4:48 p.m. Nov. 14, 2014 - PR Newswire - PRF
AbbVie to Present Results from Studies in Chronic Hepatitis C Patients with HIV-1 Co-Infection (TURQUOISE-I) and Liver Transplant Recipients (CORAL-I) at The Liver Meeting® 2014 9:00 a.m. Nov. 11, 2014 - PR Newswire - PRF
AbbVie to Present Results from Phase 2 PEARL-I Study in Genotype 4 Chronic Hepatitis C Patients at The Liver Meeting® 2014 8:00 a.m. Nov. 11, 2014 - PR Newswire - PRF
Infinity Reports Third Quarter 2014 Financial Results and Provides Company Update 4:01 p.m. Nov. 6, 2014 - BusinessWire - BZX
Technical Notes Covering Pharma Equities - AbbVie, Bristol-Myers Squibb, GlaxoSmithKline, Eli Lilly, and Teva Pharma Industries 8:50 a.m. Nov. 6, 2014 - PR Newswire - PRF
ABBVIE (ABBV) SHAREHOLDER ALERT – Andrews & Springer LLC Is Investigating AbbVie Inc. For Potential Securities Fraud and Breach of Fiduciary Duty 8:03 a.m. Nov. 5, 2014 - BusinessWire - BZX
AbbVie to Present at Credit Suisse 2014 Healthcare Conference 8:00 a.m. Nov. 5, 2014 - PR Newswire - PRF
ABBVIE INC. ALERT -- Andrews & Springer LLC is Investigating AbbVie Inc. for Potential Securities Fraud and Breach of Fiduciary Duty 8:09 a.m. Nov. 3, 2014 - GlobeNewswire
Myriad and AbbVie Sign Expanded Agreement for Tumor BRACAnalysis CDx(TM) 7:05 a.m. Nov. 3, 2014 - GlobeNewswire
CMK Select Recognized as Women's Business Enterprise 10:45 a.m. Oct. 31, 2014 - Marketwired
AbbVie Reports Third-Quarter 2014 Financial Results 7:49 a.m. Oct. 31, 2014 - PR Newswire - PRF
If You Purchased Shire plc American Depository Receipts ("ADRs"

During The Period Of June 20, 2014 And October 14, 2014 And Lost Money, Gardy & Notis, LLP Encourages You To Contact The Law Firm 8:38 a.m. Oct. 29, 2014 - PR Newswire - PRF
Compliance Notice, Dividend Announcements, New Share Repurchase Program, and Financial Results - Research Reports on Gilead, Pfizer, AbbVie, Edwards and Lilly 8:35 a.m. Oct. 29, 2014 - PR Newswire - PRF
AbbVie Named a Top Employer in Science Magazine's Annual Survey for Second Consecutive Year 8:00 a.m. Oct. 23, 2014 - PR Newswire - PRF
Merger Deal Updates, Dividend, Dispute Settlement, Regulatory Application Submission, and Preliminary Results - Research Reports on Shire, Johnson & Johnson, Merck, Amgen and HCA 9:00 a.m. Oct. 21, 2014 - PR Newswire - PRF
AbbVie Announces New $5 Billion Stock Repurchase Program and Increases Dividend 5:31 p.m. Oct. 20, 2014 - PR Newswire - PRF
Announcement Of Termination Of Proposed AbbVie And Shire Transaction 5:12 p.m. Oct. 20, 2014 - PR Newswire - PRF
Acquisition Updates, Drug Approval, Drug Development Discontinuation, and Contract Update - Research Reports on AbbVie, Gilead, Pfizer, Lilly and Aetna 8:35 a.m. Oct. 20, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

B2B Growth Hinges on Narrative Coherence, Study Shows

Clear Stories, Stronger Growth If companies can't tell a clear story that their buyers understand and believe, they're destined to stagnate. That's the blunt reality kompeld is pushing with their H2 2026 Narrative Coherence Benchmark. The report scores 150 B2B tech companies on their narrative coherence, showing there's a stark correlation between storytelling and growth....

Red Banyan Earns Top Honors in Florida for 2026

Red Banyan: A Powerhouse in Reputation Management Boy, have you ever watched a company rise through the ranks almost like a caffeine kick on a drowsy morning? That's Red Banyan for you. This outfit, right out of Fort Lauderdale, snagged the '2026 Best of Florida' award as the cream of the crop in the Business Consulting Firms category. It’s like taking home an Oscar in...

Medicare Competitive Bidding May Slash Jobs, Access

Medicare's New Program: Potential Knockout Punch? Today, we dive into Medicare's latest shake-up that might just be the unseen wrecking ball swinging toward thousands of jobs and small businesses in the healthcare sector. Two years from now, starting January 2028, the Competitive Bidding Program is set to reroute the entire landscape for suppliers of key medical products...

OrthoAtlanta Expands with Dr. Smith's Expertise Hire

OrthoAtlanta Welcomes New Orthopedic Surgeon In a world where healthcare organizations are constantly stretching their wings, this new addition of Dr. Carson J. Smith to the fold at Piedmont Orthopedics | OrthoAtlanta stands out. This isn't just some cosmetic face-lift, folks. It's a real investment in the community, not to mention a crucial broadening of what this...

Solar Fencing Revolutionizes North Texas Homes

Fences Go Solar: Welcome to the Future Land of fences and sunshine, North Texas is about to see a game changer in home improvement. Southwest Fence & Deck is rolling out the red carpet as an Authorized SOL Fence Installation Partner, putting solar power right in your backyard. Yeah, there have been sparks of innovation in plenty of fields, but who expected fences to join...

Lyric Health's AI System Promises Data-Driven Revolution

A Bold Step in Healthcare Coordination No doubt about it, healthcare is a mess. It's like trying to patch a leaking ship with duct tape—point solutions here, add-ons there, and nothing truly working in harmony. And in storms in Lyric Health, claiming they've got the answer. They've launched an AI-powered Healthcare Operating System meant to unify these disjointed pieces...

Jacob Walthour to Be Honored for Economic Leadership

The Honoring of Leadership That Goes Beyond Business In a world where financial influence often feels like it funnels into the same familiar pockets, the news of Jacob Walthour Jr.'s upcoming recognition feels like a fresh breeze of change. The Alpha Phi Alpha's Alpha Alpha Lambda Chapter is rolling out the red carpet at its Centennial Gala for Walthour, throwing him into...

Goddess Maintenance Co. Eyes BeautyMatter Award

Challenging the Haircare Norm with Confidence Goddess Maintenance Co. doesn't just draft a fresh play in the beauty industry playbook—it's ripping out the old pages and setting a new standard. This ain't your granny's haircare game anymore, folks. They're up for a 2026 BeautyMatter Award, a nod to their gut-busting innovation in the conditioner category with their star...

Finastra Recognized as 2026 Leader in Payment Platforms

Finastra Steals the Spotlight in Payments Innovation When it comes to the modern world of finance, nothing screams ‘adapt or fade into oblivion’ like the payments industry. Well, here’s a reality check from QKS Group: Finastra has snatched the spotlight in their SPARK Matrix™ for 2026 as a powerhouse in integrated bank payments platforms. Clearly, this ain’t...

2026 CEE Awards Highlight Energy Innovation Leaders

Showcasing Cutting-Edge Home Energy Innovations It's that time of year again when the brightest innovators in home energy solutions get a nod from the Consortium for Energy Efficiency (CEE). This year's Integrated Home Competition spotlighted five trailblazing products that promise to reshape how we think about energy efficiency, demand flexibility, and sheer user comfort...